Friday 6 November 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue: +11.2%
EPS: 0.00%
Free cash flow: −52.9%
Total debt: +0.31%

Quarter to September 2026, against a year earlier

79.50 4.96 −5.87%

Follow DXCM

Alert me

Market cap: $31.5B
P/E: 32.6×
Fwd P/E: 31.8×
Dividend yield: —
F-score: 8/9
Altman Z: 6.43
Beneish M: −2.70
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

DexCom, Inc. 10-Q filed Oct 24, 2024

Fiscal Q3 2024 · Period ended Sep 30, 2024 · Filed Oct 24, 2024 · accepted 5:13 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov